日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma

单细胞图谱揭示了与多发性骨髓瘤预后相关的骨髓免疫微环境失调

Pilcher, William C; Yao, Lijun; Gonzalez-Kozlova, Edgar; Pita-Juarez, Yered; Karagkouni, Dimitra; Acharya, Chaitanya R; Michaud, Marina E; Hamilton, Mark; Nanda, Shivani; Song, Yizhe; Sato, Kazuhito; Wang, Julia T; Satpathy, Sarthak; Ma, Yuling; Schulman, Jessica; D'Souza, Darwin; Jayasinghe, Reyka G; Ohlstrom, Denis; Ferguson, Katherine E; Cheloni, Giulia; Bakhtiari, Mojtaba; Pabustan, Nick; Nie, Kai; Foltz, Jennifer A; Saldarriaga, Isabella; Alaaeldin, Rania; Lepisto, Eva; Chen, Rachel; Fiala, Mark A; Thomas, Beena E; Cook, April; Santos, Junia Vieira Dos; I-Ling, Chiang; Figueiredo, Igor; Fortier, Julie; Slade, Michael; Oh, Stephen T; Rettig, Michael P; Anderson, Emilie; Li, Ying; Dasari, Surendra; Strausbauch, Michael A; Simon, Vernadette A; Radkevich, Emir; Rahman, Adeeb H; Chen, Zhihong; Lagana, Alessandro; DiPersio, John F; Rosenblatt, Jacalyn; Kim-Schulze, Seunghee; Lonial, Sagar; Kumar, Shaji; Bhasin, Swati S; Kourelis, Taxiarchis; Dhodapkar, Madhav V; Vij, Ravi; Avigan, David; Cho, Hearn J; Mulligan, George; Ding, Li; Gnjatic, Sacha; Vlachos, Ioannis S; Bhasin, Manoj

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial

新辅助帕博西尼联合阿那曲唑治疗内分泌耐药的雌激素受体阳性/HER2阴性乳腺癌疗效的生物标志物:一项II期试验

Kong, Tim; Mabry, Alex; Highkin, Maureen; Wang, Anthony Z; Hoog, Jeremy; Guo, Zhanfang; Gonzales-Gonzales, Adrian; Thomas, Shana; Song, Yingduo; Gao, Feng; Opyrchal, Mateusz; Peterson, Lindsay; Ademuyiwa, Foluso; Margenthaler, Julie; Aft, Rebecca; Glover-Collins, Katherine; Nehring, Leslie; Tao, Yu; Sanati, Souzan; Hagemann, Ian S; Boulos, Fouad; Holt, Matthew; Ding, Li; Zhu, Wenge; Oh, Stephen T; Wang, Jianxin; Witkiewicz, Agnieszka K; Knudsen, Erik S; Bose, Ron; Weber, Jason D; Goetz, Matthew; Northfelt, Donald; Luo, Jingqin; Ma, Cynthia X

JAK inhibitor selection in challenging scenarios of myelofibrosis: a review

在骨髓纤维化复杂情况下选择JAK抑制剂:综述

Vachhani, Pankit; Mesa, Ruben; Mascarenhas, John; Rampal, Raajit; Oh, Stephen T; Vannucchi, Alessandro Maria; Fox, Maria Laura; Palandri, Francesca; Passamonti, Francesco; Kiladjian, Jean-Jacques; Azimi, Mahshid; Harrison, Claire; Bose, Prithviraj

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

Pelabresib联合ruxolitinib治疗JAK抑制剂初治骨髓纤维化:一项随机3期试验

Rampal, Raajit K; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T; Vannucchi, Alessandro M; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen T; Kuykendall, Andrew T; Patriarca, Andrea; Álvarez-Larrán, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Scandura, Joseph M; Lavie, David; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Boxhammer, Rainer; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire N; Mascarenhas, John

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response

监测克隆负荷可作为骨髓增生异常肿瘤治疗反应的替代指标,以替代原始细胞计数。

Jacoby, Meagan A; Duncavage, Eric D; Khanna, Ajay; Chang, Gue Su; Nonavinkere Srivatsan, Sridhar; Miller, Christopher A; Gao, Feng; Robinson, Josh; Shao, Jin; Fulton, Robert S; Fronick, Catrina C; O'Laughlin, Michelle; Heath, Sharon E; Brendel, Kimberly; Chavez, Monique; DiPersio, John F; Abboud, Camille N; Stockerl-Goldstein, Keith; Westervelt, Peter; Cashen, Amanda; Pusic, Iskra; Oh, Stephen T; Welch, John S; Wells, Denise A; Loken, Michael R; Uy, Geoffrey L; Walter, Matthew J

A proteogenomic gene signature defines prognostic subgroups highlighting PI3K/AKT/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies

蛋白质基因组学特征定义了预后亚组,突显了PI3K/AKT/mTOR信号通路在髓系恶性肿瘤治疗中的脆弱性。

He, Fan; Lin, Shuyang; Gao, Bei; Ramesh, Varun; Kim, Alexander B; Kong, Tim; Fisher, Daniel A C; Letson, Christopher T; Brakhane, Molly; Fulbright, Mary; Yu, Yanbo; Sardiello, Marco; Di Paola, Jorge; Sykes, Stephen M; Oh, Stephen T

SF3B1K700E Neoantigen Is a CD8+ T-cell Target Shared across Human Myeloid Neoplasms

SF3B1K700E新抗原是人类髓系肿瘤共有的CD8+ T细胞靶点

Biernacki, Melinda A; Lok, Jessica; Foster, Kimberly A; Cummings, Carrie; Busch, Stephanie; Black, R Graeme; Ray, Suhita; Baquero Galvis, Laura; Monahan, Tim; Oh, Stephen T; Oehler, Vivian G; Stirewalt, Derek L; Wu, David; Deeg, H Joachim; Doulatov, Sergei; Bleakley, Marie

A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial

一项在美国和加拿大开展的多中心研究旨在评估罗培干扰素α-2b-njft治疗原发性血小板增多症患者的疗效、安全性和耐受性:EXCEED-ET试验

Masarova, Lucia; Reeves, Brandi N; El Chaer, Firas; Foltz, Lynda; Tashi, Tsewang; Abu-Zeinah, Ghaith; Lucas, Jennifer; Halpern, Anna B; Maze, Dawn; Qin, Albert; Safah, Hana; Lan, Fengshuo; O'Connell, Casey L; Goel, Swati; Rein, Lindsay; Fang, Bruno; How, Joan; Babu, Sunil; Li, Zhuoyan; Cerquozzi, Sonia; Oh, Stephen T; Hunter, Anthony M; Podoltsev, Nikolai; Vachhani, Pankit; Yacoub, Abdulraheem; Cunningham, Julia M; Hillis, Christopher; Otoukesh, Salman; Zagrijtschuk, Oleh; Castro, Henry; Bose, Prithviraj

JAK2 (V617F) Myeloproliferative Neoplasms Support Parallel Evolution of Independent Leukemic Clones

JAK2 (V617F) 骨髓增生性肿瘤支持独立白血病克隆的平行进化

Parsons, Tyler M; Krishnan, Aishwarya; Raj, Infencia Xavier; Young, Andrew L; O'Leary, David R; Arand, Jason; Cox, Maggie; Oh, Stephen T; Challen, Grant A

Unfolded protein response signaling promotes myeloid cell production and cooperates with oncogenic mutation.

未折叠蛋白反应信号促进髓系细胞生成,并与致癌突变协同作用。

Choi Hyunjoo, Jung Sang-Eun, Paik Hyojung, Earth Yesenia, Yi Jiye, Cox Maggie J, Oh Stephen T, Kang Yoon-A